Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development | White Papers
Search Refinements

Drug Discovery & Development White Papers

View white papers from other Pharmaceutical sectors:
121-135 of 138 results
Chinese Regulatory Changes for Human Serum and Plasma Exports Trigger Potential Delays
| By World Courier
Researchers conducting or planning to conduct clinical trials in China should be aware of new regulatory changes that specifically affect export shipments of human serum and plasma from China and the delays that the new administrative process may create. This free white paper includes a list of these major changes associated with the new regulations.
Drug Research > Drug Discovery & Development > White Papers
Document Compliance Management
| By Brainloop
A DCM system covers the entire lifecycle of a document with no gaps. As a consequence, the document always remains under the system's watchful eye, even when it is opened, edited or stored on the desktop.
Drug Research > Drug Discovery & Development > White Papers
Functional Imaging Using Computer Methods to Improve Respiratory Drug Development
| By FluidDA
Within the pharmaceutical industry it has become more and more apparent that the cost for the development of new products increases while the number of products that reaches the market declines. One of the causes for this phenomenon is the limited sensitivity of existing lung function tests to detect changes in pulmonary function in an early stage. Therefore within the field of respiratory medicine a consensus is starting to form around the need for new outcome parameters.
Drug Research > Drug Discovery & Development > White Papers
GA-Map™ Technology
| By Genetic Analysis
Genetic Analysis AS has developed a DNA-based platform technology that allows for simultaneous analysis of a large number of similar (but not identical) gene fragments in one reaction. For a technical description please download this free white paper.
Drug Research > Drug Discovery & Development > White Papers
Identifying and Exploiting Opportunities for Pharmacogenetics and Other Predictive Factors
| By Exploristics
Exploristics offer practical analysis tools that are built on basic principles and allow the evaluation of opportunities for PGx. This evaluation can be performed before the initiation of an extensive and costly experiment.
Drug Research > Drug Discovery & Development > White Papers
Latin America Emerges as World Competitor for Global Trials Despite Tough Regulatory Environment
| By World Courier
This article examines the regulatory atmosphere that prevails throughout Latin America and considers options that can streamline the timely flow of clinical trial materials through the supply chain.
Drug Research > Drug Discovery & Development > White Papers
Live Cell Imaging of Drug Effects on Golgi Morpholgy Using the CELLview™ Cell Culture Dish
| By Greiner Bio-One
Fluorescent and time lapse microscopy, advantages of multiplex analysis and the Golgi apparatus. Please donwload this free white paper for more information.
Drug Research > Drug Discovery & Development > White Papers
Management and Analysis of Biomarker Data
| By Exploristics
There is great expectation in the Pharmaceutical Industry that the era of personalised medicine will deliver safer and more effective treatments (Jørgensen & Winther, 2009). This promise is made possible by the emergence of new technologies and data acquisition platforms that can generate enormous amounts of patient-level biomarker data to characterise biological processes and explain response to treatment.
Drug Research > Drug Discovery & Development > White Papers
Peptide Professionals
| By PolyPeptide Group
This free comprehensive brochure gives details on The PolyPeptide Group including information on services provided.
Drug Research > Drug Discovery & Development > White Papers
Profiling Pharmaceuticals with Neuronal Network Cultures
| By NeuroProof
Our advanced combination of primary neuronal cell cultures on MEA neurochips and sophisticated methods of data analysis is a major step forward in target validation, which remains as one of the bottlenecks in drug discovery.
Drug Research > Drug Discovery & Development > White Papers
Protecting Sensitive Information in Life Sciences Organisations
| By Brainloop
Critical business processes in biotech companies involve highly confidential, important documents that need to be safely accessed by external partners and potential licensees. Find a new way to protect this confidential documents.
Drug Research > Drug Discovery & Development > White Papers
Seamless Life Sciences Collaboration
| By Brainloop
Speeding up your time to market: Seamless online collaboration in the biopharmaceutical industry
Drug Research > Drug Discovery & Development > White Papers
Taming China's Clinical Trial 'Dragon'
| By World Courier
With a population in excess of 1.3 billion and low technical costs, China is a highly attractive venue for clinical trials. In this article, current regulations and permit requirements are examined and a transportation case study is presented. Local solutions and important considerations for choosing appropriate "in country" service providers are also discussed.
Drug Research > Drug Discovery & Development > White Papers
The Informed Design and Validation of Quality of Life Questionnaires and Rating Scales Using Rasch Analysis
| By Exploristics
This free white paper describes how some of the additional outputs from Rasch analysis can provide information beyond that of a simple analysis of the QoL data during the creation and validation of a new instrument or to understand and quantify responses following a clinical study.
Drug Research > Drug Discovery & Development > White Papers
The Urgent Need for Qualified Transportation Providers in Global Clinical Research
| By World Courier
In light of sobering statistics from the MHRA, WHO and others about the quality of temperature-controlled drugs and medicinal products arriving at global research sites, regulatory agencies and pharmaceutical companies alike are demanding that every party involved in the pharmaceutical supply chain conform to GxP guidelines. This article outlines the main precepts of GxP as it applies to the pharmaceutical transport industry and offers insight on securing the global CTM supply chain.
Drug Research > Drug Discovery & Development > White Papers
121-135 of 138 results